Cyclerion Therapeutics, Inc.(CYCN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CYCN Cyclerion Therapeutics, Inc.

盘前交易 02-24 05:31:34 EST

1.32

-0.02

-1.49%

最高1.34	最低1.27	成交量2.30万
今开1.31	昨收1.34	日振幅5.22%
总市值518.14万	流通市值421.03万	总股本392.53万
成交额3.02万	换手率0.72%	流通股本318.96万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CYCN","market":"US","secType":"STK","nameCN":"Cyclerion Therapeutics, Inc.","latestPrice":1.32,"timestamp":1771880400000,"preClose":1.34,"halted":0,"volume":23006,"delay":0,"changeRate":-0.01492537313432837,"floatShares":3189600,"shares":3925314,"eps":-0.767874,"marketStatus":"盘前交易","change":-0.02,"latestTime":"02-24 05:31:34 EST","open":1.31,"high":1.34,"low":1.27,"amount":30191.940204200004,"amplitude":0.052239,"askPrice":1.44,"askSize":200,"bidPrice":1.13,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.767874,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771943400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.32,"postHourTrading":{"tag":"盘后","latestPrice":1.32,"preClose":1.32,"latestTime":"17:13 EST","volume":477,"amount":629.53,"timestamp":1771884839530,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5537263267566078,"impliedVol":5.457,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/CYCN","defaultTab":"news","newsList":[{"id":"1148173047","title":"Cyclerion Therapeutics 就 Cyc-126 二期概念验证研究取得进展：获FDA反馈并成立临床顾问委员会","url":"https://stock-news.laohu8.com/highlight/detail?id=1148173047","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148173047?lang=zh_cn&edition=full","pubTime":"2026-02-17 20:01","pubTimestamp":1771329687,"startTime":"0","endTime":"0","summary":"生物制药公司 Cyclerion Therapeutics, Inc. 近日宣布，其在研药物 Cyc-126 的二期概念验证研究取得了重要进展。公司已获得美国食品药品监督管理局的反馈，并正式组建了临床顾问委员会，为后续临床开发计划的推进奠定了坚实基础。\n这一系列举措标志着 Cyc-126 项目的开发进入了一个新的关键阶段。获得监管机构的指导性意见，有助于优化试验设计。而顶尖专家团队的加入，将为研究提供宝贵的科学和临床见解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CYCN"],"gpt_icon":0},{"id":"1109536982","title":"Cyclerion Therapeutics与Medsteer达成战略合作 并推进Cyc-126治疗难治性抑郁症的二期概念验证研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1109536982","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109536982?lang=zh_cn&edition=full","pubTime":"2026-01-06 05:04","pubTimestamp":1767647051,"startTime":"0","endTime":"0","summary":"Cyclerion Therapeutics公司宣布与Medsteer达成一项战略合作协议，双方将携手推进其候选药物Cyc-126在难治性抑郁症治疗领域的研发进程。目前，公司在启动Cyc-126二期概念验证研究方面取得了显著进展，标志着该创新疗法向临床验证迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CYCN"],"gpt_icon":0},{"id":"1125996418","title":"Cyclerion Therapeutics：根据许可协议MIT有资格获得高达440万美元里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1125996418","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125996418?lang=zh_cn&edition=full","pubTime":"2025-09-24 04:20","pubTimestamp":1758658819,"startTime":"0","endTime":"0","summary":"根据SEC文件显示，Cyclerion Therapeutics与MIT签署的许可协议中，MIT有资格获得总额高达440万美元的里程碑付款。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYCN","BK4139"],"gpt_icon":0},{"id":"2511652548","title":"Cyclerion Therapeutics, Inc.盘中异动 早盘快速下挫7.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511652548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511652548?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:42","pubTimestamp":1739457779,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时42分，Cyclerion Therapeutics, Inc.股票出现异动，股价大幅下挫7.14%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213224300a244adf4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213224300a244adf4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CYCN","BK4139"],"gpt_icon":0},{"id":"2508457692","title":"Cyclerion Therapeutics, Inc.盘中异动 快速下挫6.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508457692?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:31","pubTimestamp":1738679511,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时31分，Cyclerion Therapeutics, Inc.股票出现波动，股价急速下挫6.95%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223151abc22800&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223151abc22800&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCN","BK4139","LENZ"],"gpt_icon":0},{"id":"2507965088","title":"Cyclerion Therapeutics, Inc.股价拉升28.74% 市值涨254.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507965088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507965088?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:31","pubTimestamp":1738333891,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时31分，Cyclerion Therapeutics, Inc.股票出现波动，股价快速拉升28.74%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.62%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223131a23541fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131223131a23541fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCN","LENZ"],"gpt_icon":0},{"id":"2506051443","title":"Cyclerion Therapeutics, Inc.盘中异动 早盘快速上涨9.82%报2.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506051443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506051443?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:02","pubTimestamp":1737990121,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时02分，Cyclerion Therapeutics, Inc.股票出现波动，股价快速拉升9.82%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127230201abba6601&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127230201abba6601&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCN","BK4139","LENZ"],"gpt_icon":0},{"id":"2500643512","title":"Cyclerion Therapeutics, Inc.盘中异动 大幅跳水6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500643512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500643512?lang=zh_cn&edition=full","pubTime":"2025-01-01 01:38","pubTimestamp":1735666695,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日01时38分，Cyclerion Therapeutics, Inc.股票出现波动，股价急速下挫6.09%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010101381595f452e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010101381595f452e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CYCN"],"gpt_icon":0},{"id":"2494671385","title":"Cyclerion Therapeutics, Inc.盘中异动 早盘股价大涨6.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494671385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494671385?lang=zh_cn&edition=full","pubTime":"2024-12-27 22:30","pubTimestamp":1735309826,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日22时30分，Cyclerion Therapeutics, Inc.股票出现波动，股价快速拉升6.93%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412272230279851d25a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412272230279851d25a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCN","LENZ","BK4139"],"gpt_icon":0},{"id":"2492533440","title":"Cyclerion Therapeutics, Inc.股价飙升15.25% 市值涨28.02万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492533440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492533440?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:31","pubTimestamp":1734705109,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时31分，Cyclerion Therapeutics, Inc.股票出现波动，股价大幅拉升15.25%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122022314995ea9c29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122022314995ea9c29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CYCN"],"gpt_icon":0},{"id":"2490019340","title":"Cyclerion Therapeutics, Inc.股价拉升10.25% 市值涨193.76万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490019340","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490019340?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:31","pubTimestamp":1733841080,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时31分，Cyclerion Therapeutics, Inc.股票出现异动，股价急速上涨10.25%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223120984b0bb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210223120984b0bb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCN","BK4139","LENZ"],"gpt_icon":1},{"id":"2488945777","title":"Cyclerion Therapeutics, Inc.盘中异动 早盘股价大跌5.56%报2.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488945777","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488945777?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:32","pubTimestamp":1733236328,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时32分，Cyclerion Therapeutics, Inc.股票出现异动，股价快速跳水5.56%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223208a26995b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223208a26995b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCN","LENZ"],"gpt_icon":0},{"id":"2486682701","title":"Cyclerion Therapeutics, Inc.股价拉升50.59% 市值涨280.77万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486682701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486682701?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:32","pubTimestamp":1732717929,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时32分，Cyclerion Therapeutics, Inc.股票出现异动，股价快速上涨50.59%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223209abe36a15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223209abe36a15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCN","LENZ","BK4139"],"gpt_icon":0},{"id":"2486008005","title":"Cyclerion Therapeutics, Inc.盘中异动 股价大涨11.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486008005","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486008005?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:32","pubTimestamp":1732545144,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时32分，Cyclerion Therapeutics, Inc.股票出现异动，股价急速上涨11.19%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223224abddfa3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223224abddfa3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CYCN","LENZ"],"gpt_icon":0},{"id":"2481536549","title":"Cyclerion Therapeutics, Inc.盘中异动 大幅下跌6.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481536549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481536549?lang=zh_cn&edition=full","pubTime":"2024-11-05 00:24","pubTimestamp":1730737462,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日00时24分，Cyclerion Therapeutics, Inc.股票出现异动，股价急速下跌6.44%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105002422a2157d61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105002422a2157d61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCN","LENZ","BK4139"],"gpt_icon":0},{"id":"2479080472","title":"Cyclerion Therapeutics, Inc.股价拉升11.67% 市值涨20.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479080472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479080472?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:30","pubTimestamp":1730381429,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时30分，Cyclerion Therapeutics, Inc.股票出现异动，股价大幅拉升11.67%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213029971a383b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213029971a383b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCN","BK4139","LENZ"],"gpt_icon":0},{"id":"2479288277","title":"Cyclerion Therapeutics, Inc.盘中异动 急速拉升7.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479288277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479288277?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:42","pubTimestamp":1730209367,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时42分，Cyclerion Therapeutics, Inc.股票出现波动，股价快速上涨7.64%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921424898e3f1b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921424898e3f1b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CYCN"],"gpt_icon":0},{"id":"2477863039","title":"Cyclerion Therapeutics, Inc.盘中异动 急速下跌6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477863039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477863039?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:34","pubTimestamp":1729517655,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日21时34分，Cyclerion Therapeutics, Inc.股票出现波动，股价快速下挫6.00%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121341598e3d845&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102121341598e3d845&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CYCN","BK4139","LENZ"],"gpt_icon":0},{"id":"2475915469","title":"Cyclerion Therapeutics, Inc.盘中异动 早盘股价大涨11.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475915469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475915469?lang=zh_cn&edition=full","pubTime":"2024-10-16 22:05","pubTimestamp":1729087504,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日22时05分，Cyclerion Therapeutics, Inc.股票出现异动，股价大幅上涨11.11%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410162205049f47e42e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410162205049f47e42e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CYCN","BK4139"],"gpt_icon":0},{"id":"2472461616","title":"Cyclerion Therapeutics, Inc.盘中异动 早盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472461616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472461616?lang=zh_cn&edition=full","pubTime":"2024-10-03 21:31","pubTimestamp":1727962276,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日21时31分，Cyclerion Therapeutics, Inc.股票出现异动，股价急速上涨5.18%。Cyclerion Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。Cyclerion Therapeutics, Inc.公司简介：Cyclerion Therapeutics Inc是一家临床阶段的生物制药公司，利用可溶性鸟苷酸环化酶药理学的力量来发现、开发和商业化针对严重的疾病和孤儿病的突破性疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003213116958dc555&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003213116958dc555&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CYCN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cyclerion.com","stockEarnings":[{"period":"1week","weight":0.056},{"period":"1month","weight":-0.1429},{"period":"3month","weight":-0.102},{"period":"6month","weight":-0.4864},{"period":"1year","weight":-0.5319},{"period":"ytd","weight":0.0394}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0109},{"period":"6month","weight":0.0553},{"period":"1year","weight":0.1374},{"period":"ytd","weight":0.0007}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cyclerion Therapeutics, Inc.于2018年9月6日在马萨诸塞州注册成立。Cyclerion是一家生物制药公司，专注于在中枢神经系统和外周使用新型可溶性鸟苷酸环化酶刺激剂治疗严重疾病。一氧化氮sGC环鸟苷一磷酸信号通路是精确控制全身生理关键方面的根本机制。NO-SGC-cGMP通路调节CNS和外周的多种关键生物学功能，已成功地被几种药物靶向。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.030269},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.008877},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.154604},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.03238},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.025425},{"month":6,"riseRate":0.428571,"avgChangeRate":0.033565},{"month":7,"riseRate":0.285714,"avgChangeRate":0.028017},{"month":8,"riseRate":0.571429,"avgChangeRate":0.104709},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.020687},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.324291},{"month":11,"riseRate":0.285714,"avgChangeRate":0.0186},{"month":12,"riseRate":0.428571,"avgChangeRate":0.106805}],"exchange":"NASDAQ","name":"Cyclerion Therapeutics, Inc.","nameEN":"Cyclerion Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cyclerion Therapeutics, Inc.(CYCN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cyclerion Therapeutics, Inc.(CYCN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cyclerion Therapeutics, Inc.,CYCN,Cyclerion Therapeutics, Inc.股票,Cyclerion Therapeutics, Inc.股票老虎,Cyclerion Therapeutics, Inc.股票老虎国际,Cyclerion Therapeutics, Inc.行情,Cyclerion Therapeutics, Inc.股票行情,Cyclerion Therapeutics, Inc.股价,Cyclerion Therapeutics, Inc.股市,Cyclerion Therapeutics, Inc.股票价格,Cyclerion Therapeutics, Inc.股票交易,Cyclerion Therapeutics, Inc.股票购买,Cyclerion Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cyclerion Therapeutics, Inc.(CYCN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cyclerion Therapeutics, Inc.(CYCN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}